Cytarabine and white blood cell count decreased 
Cytarabine and white blood cell count decreased Patient Reports February 11, 2012
Cytarabine Side Effects Report #5073361-0
Cytarabine side effect was reported by a Consumer or non-health professional from UNITED STATES on July 06, 2005. Female patient, 56 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Cytarabine. After drug was administered, patient experienced the following side effects: dizziness
, escherichia infection, febrile neutropenia, nausea , white blood cell count decreased. Cytarabine dosage: unknown. During the same period patient was treated with ETOPOSIDE, MITOXANTRONE, LEVOFLOXACIN, VALTREX. Patient was hospitalized. Patient recovered.Cytarabine Side Effects Report #5217011-9
Cytarabine side effect was reported by a Consumer or non-health professional from CANADA on Jan 09, 2007. Male patient, 78 years of age, was diagnosed with acute myeloid leukaemia and was treated with Cytarabine. After drug was administered, patient experienced the following side effects: haematocrit decreased, haemoglobin decreased, mucosal inflammation, platelet count decreased, red blood cell count decreased, white blood cell count decreased. Cytarabine dosage: 36 MG PER_CYCLE SC. Patient was hospitalized. Patient recovered.
Cytarabine Side Effects Report #5268680-9
Cytarabine side effect was reported by a Health Professional from CANADA on Mar 05, 2007. Male patient, 78 years of age, was diagnosed with acute myeloid leukaemia and was treated with Cytarabine. After drug was administered, patient experienced the following side effects: agitation, anaemia, disease progression, dyspnoea, platelet count decreased, restlessness, stomatitis, white blood cell count decreased. Cytarabine dosage: 36 MG PER_CYCLE SC. During the same period patient was treated with TRANSEXAMIC ACID, RANITIDINE, ALTACE, TEMAZEPAM, COVERSYL, GARASONE, TYLENOL, LIPITOR. Patient was hospitalized. Patient died.
Cytarabine Side Effects Report #5290063-6
Cytarabine side effect was reported by a Health Professional from CANADA on Mar 23, 2007. Male patient, 69 years of age, was diagnosed with acute myeloid leukaemia and was treated with Cytarabine. After drug was administered, patient experienced the following side effects: blood culture positive, febrile neutropenia, haematocrit decreased, haemoglobin decreased, platelet count increased, streptococcal infection
, white blood cell count decreased. Cytarabine dosage: 20 MG/M2 PER_CYCLE SC. During the same period patient was treated with ISONIAZID, VITAMIN B6, SYNTHROID. Patient was hospitalized. Patient recovered.Cytarabine Side Effects Report #5082568-8
Cytarabine side effect was reported by a Physician from UNITED STATES on Aug 04, 2006. Male patient, 68 years of age, weighting 147.9 lb, was diagnosed with acute myeloid leukaemia and was treated with Cytarabine. After drug was administered, patient experienced the following side effects: enterococcal infection, hypernatraemia, mucosal inflammation, neutropenia, white blood cell count decreased. Cytarabine dosage: unknown. During the same period patient was treated with MITOXANTRONE, ETOPOSIDE, AMBISOME, ZOSYN, VANCOMYCIN, VALTREX, DEXAMETHASONE. Patient was hospitalized. Patient recovered.
Cytarabine Side Effects Report #5286038-3
Cytarabine side effect was reported by a Health Professional from UNITED STATES on Mar 22, 2007. Male patient, 67 years of age, weighting 207.5 lb, was diagnosed with acute myeloid leukaemia and was treated with Cytarabine. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, cerebral haemorrhage, disease progression, haemoglobin decreased, subarachnoid haemorrhage, thrombocytopenia, white blood cell count decreased. Cytarabine dosage: unknown. During the same period patient was treated with ETOPOSIDE, MITOXANTRONE. Patient died on 01/10/2007.
Cytarabine Side Effects Report #5290064-8
Cytarabine side effect was reported by a Health Professional from TAIWAN, PROVINCE OF CHINA on Mar 23, 2007. Female patient, 65 years of age, was diagnosed with acute myeloid leukaemia and was treated with Cytarabine. After drug was administered, patient experienced the following side effects: blood pressure increased, haemoglobin decreased, lymphadenopathy, parapharyngeal abscess, pneumonia
, red blood cell count decreased, white blood cell count decreased. Cytarabine dosage: 20 MG DAILY SC. During the same period patient was treated with NYSTATIN, RIFATAR, ETHAMBUTOL HYDROCHLORIDE, VITAMIN B6. Patient was hospitalized. Patient recovered.Cytarabine Side Effects Report #4705930-9
Cytarabine side effect was reported by a Consumer or non-health professional from on June 07, 2005. Female patient, 65 years of age, weighting 143.3 lb, was diagnosed with acute myeloid leukaemia and was treated with Cytarabine. After drug was administered, patient experienced the following side effects: gastrointestinal haemorrhage, haemoglobin decreased, neutropenia, proctalgia, tachycardia, thrombocytopenia, white blood cell count decreased. Cytarabine dosage: 100 MG/M2 OTH IV. During the same period patient was treated with DAUNORUBICIN. Patient was hospitalized. Patient recovered.
Cytarabine Side Effects Report #5372450-0
Cytarabine side effect was reported by a Health Professional from UNITED STATES on June 20, 2007. Male patient, 64 years of age, weighting 187.2 lb, was diagnosed with acute myeloid leukaemia and was treated with Cytarabine. After drug was administered, patient experienced the following side effects: dysphagia, febrile neutropenia, mucosal inflammation, oral pain, white blood cell count decreased. Cytarabine dosage: unknown. During the same period patient was treated with MITOXANTRONE, ETOPOSIDE. Patient was hospitalized. Patient recovered.
Cytarabine Side Effects Report #4982224-8
Cytarabine side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 11, 2006. Male patient, 55 years of age, was diagnosed with acute myeloid leukaemia and was treated with Cytarabine. After drug was administered, patient experienced the following side effects: bacteraemia, catheter related infection, diarrhoea, epigastric discomfort, febrile neutropenia, streptococcal infection
, white blood cell count decreased. Cytarabine dosage: unknown. During the same period patient was treated with ETOPOSIDE, MITOXANTRONE, CARVEDILOL, DYAZIDE, CLONIDINE, GLIPIZIDE, LIPITOR, GABAPENTIN. Patient was hospitalized. Patient recovered.Cytarabine Side Effects Report #4982242-X
Cytarabine side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 11, 2006. Female patient, 53 years of age, weighting 131.0 lb, was diagnosed with acute myeloid leukaemia and was treated with Cytarabine. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, csf test abnormal, headache
, malignant neoplasm progression, neoplasm malignant, nervous system disorder, platelet count decreased, white blood cell count decreased. Cytarabine dosage: unknown. During the same period patient was treated with MITOXANTRONE, ETOPOSIDE, SYNTHROID, IMITREX, VORICONAZOLE, FAMVIR. Patient was hospitalized. Patient recovered.Cytarabine Side Effects Report #5176928-4
Cytarabine side effect was reported by a Health Professional from UNITED STATES on Nov 28, 2006. Male patient, 46 years of age, weighting 179.9 lb, was diagnosed with acute myeloid leukaemia and was treated with Cytarabine. After drug was administered, patient experienced the following side effects: febrile neutropenia, white blood cell count decreased. Cytarabine dosage: unknown. Patient recovered.
Cytarabine Side Effects Report #5043933-8
Cytarabine side effect was reported by a Health Professional from SERBIA AND MONTENEGRO on June 15, 2006. Male patient, 37 years of age, was diagnosed with acute myeloid leukaemia and was treated with Cytarabine. After drug was administered, patient experienced the following side effects: haemoglobin decreased, neutropenic colitis, white blood cell count decreased. Cytarabine dosage: 200 MG BID IV. During the same period patient was treated with VEPESID, ADRIBLASTINE. Patient recovered.
Cytarabine Side Effects Report #5066530-7
Cytarabine side effect was reported by a Physician from UNITED STATES on July 19, 2006. Female patient, 31 years of age, weighting 179.9 lb, was diagnosed with acute myeloid leukaemia and was treated with Cytarabine. After drug was administered, patient experienced the following side effects: febrile neutropenia, lymphocyte count decreased, platelet count decreased, white blood cell count decreased. Cytarabine dosage: 2835 MG BID IV. During the same period patient was treated with MEDROXYPROGESTERONE ACETATE, MOXIFLOXACIN, ACYCLOVIR, PROCHLORPERAZINE MALEATE, VANCOMYCIN, CITALOPRAM HYDROBROMIDE. Patient was hospitalized. Patient recovered.
Cytarabine Side Effects Report #5101917-5
Cytarabine side effect was reported by a Physician from UNITED STATES on Aug 28, 2006. Female patient, 31 years of age, weighting 179.9 lb, was diagnosed with acute myeloid leukaemia and was treated with Cytarabine. After drug was administered, patient experienced the following side effects: atelectasis, disease recurrence, febrile neutropenia, platelet count decreased, staphylococcal bacteraemia, white blood cell count decreased. Cytarabine dosage: 2835 MG BID IV. During the same period patient was treated with MEDROXYPROGESTERONE ACETATE, MOXIFLOXACIN, ACYCLOVIR, PROCHLORPERAZINE MALEATE, VANCOMYCIN, CITALOPRAM HYDROBROMIDE, ITRACONAZOLE, ROCEPHIN. Patient was hospitalized. Patient recovered.
Cytarabine Side Effects Report #5008887-9
Cytarabine side effect was reported by a Physician from UNITED STATES on May 12, 2006. Female patient, 30 years of age, was diagnosed with acute myeloid leukaemia and was treated with Cytarabine. After drug was administered, patient experienced the following side effects: meningitis bacterial, platelet count decreased, white blood cell count decreased. Cytarabine dosage: unknown. Patient recovered.
Cytarabine Side Effects Report #5020907-4
Cytarabine side effect was reported by a Physician from UNITED STATES on May 26, 2006. Female patient, 30 years of age, was diagnosed with acute myeloid leukaemia and was treated with Cytarabine. After drug was administered, patient experienced the following side effects: brain damage, meningitis bacterial, paralysis
, platelet count decreased, white blood cell count decreased. Cytarabine dosage: 100MG/M2/IV OVER 24 HOURS FOR. During the same period patient was treated with GENTAMICIN, FORTAZ, IDARUBICIN, DEXAMETHASONE, ANZEMET. Patient recovered.Cytarabine Side Effects Report #4750371-1
Cytarabine side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 19, 2005. Female patient, weighting 260.1 lb, was diagnosed with acute myeloid leukaemia and was treated with Cytarabine. After drug was administered, patient experienced the following side effects: haemorrhage intracranial, platelet count decreased, white blood cell count decreased. Cytarabine dosage: unknown. During the same period patient was treated with GCSF. Patient was hospitalized. Patient died on 08/17/2005.
Cytarabine Side Effects Report #4837106-9
Cytarabine side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 21, 2005. Female patient, weighting 138.5 lb, was diagnosed with acute lymphocytic leukaemia and was treated with Cytarabine. After drug was administered, patient experienced the following side effects: chest pain
, pneumonia , white blood cell count decreased. Cytarabine dosage: unknown. During the same period patient was treated with VINCRISTINE, DEXAMETHASONE, DAUNORUBICIN, PEG ASPARAGINASE, METHOTREXATE. Patient died on 11/12/2005.Cytarabine Side Effects Report #4613685-1
Cytarabine side effect was reported by a Consumer or non-health professional from on Feb 23, 2005. Female patient, 30 years of age, was treated with Cytarabine. After drug was administered, patient experienced the following side effects: blood creatinine increased, body temperature increased, white blood cell count decreased. Cytarabine dosage: 200 MG/M2 PER_CYCLE IV. Patient recovered.
Cytarabine Side Effects Report #5316623-1
Cytarabine side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 30, 2007. Male patient, weighting 173.7 lb, was treated with Cytarabine. After drug was administered, patient experienced the following side effects: neutropenic sepsis, platelet count decreased, tachycardia, white blood cell count decreased. Cytarabine dosage: 4000 MG. Patient was hospitalized. Patient recovered.
Cytarabine Side Effects Report #5068974-6
Cytarabine side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 01, 2006. Male patient, weighting 265.0 lb, was treated with Cytarabine. After drug was administered, patient experienced the following side effects: central line infection, neutrophil count decreased, white blood cell count decreased. Cytarabine dosage: unknown. During the same period patient was treated with ETOPOSIDE. Patient was hospitalized. Patient recovered.
Cytarabine Side Effects Report #5143980-1
Cytarabine side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 02, 2006. Male patient, weighting 136.7 lb, was treated with Cytarabine. After drug was administered, patient experienced the following side effects: haematocrit decreased, haemoglobin decreased, hypotension, neutrophil count decreased, platelet count decreased, pyrexia, white blood cell count decreased. Cytarabine dosage: 1760 MG. Patient was hospitalized. Patient recovered.
Cytarabine Side Effects Report #5397657-8
Cytarabine side effect was reported by a Consumer or non-health professional from UNITED STATES on July 23, 2007. Female patient, weighting 141.1 lb, was treated with Cytarabine. After drug was administered, patient experienced the following side effects: chromaturia, haemoglobin decreased, hypokalaemia, neutropenia, oral pain, pharyngolaryngeal pain, pyrexia, white blood cell count decreased. Cytarabine dosage: 3000 MG. During the same period patient was treated with ETOPOSIDE, IFOSFAMIDE, LEUCOVORIN CALCIUM, MESNA, METHOTREXATE, RITUXIMAB, VINCRISTINE SULPHATE, NEUPOGEN. Patient was hospitalized. Patient recovered.
Cytarabine Side Effects Report #5400098-8
Cytarabine side effect was reported by a Consumer or non-health professional from UNITED STATES on July 26, 2007. Female patient, weighting 200.6 lb, was treated with Cytarabine. After drug was administered, patient experienced the following side effects: diarrhoea, febrile neutropenia, haemoglobin decreased, platelet count decreased, white blood cell count decreased. Cytarabine dosage: unknown. During the same period patient was treated with ETOPOSIDE. Patient was hospitalized. Patient recovered.
Cytarabine Side Effects Report #5679973-5
Cytarabine side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 25, 2008. Female patient, weighting 168.9 lb, was treated with Cytarabine. After drug was administered, patient experienced the following side effects: blood culture positive, escherichia infection, haemoglobin decreased, platelet count decreased, white blood cell count decreased. Cytarabine dosage: 14400 MG. During the same period patient was treated with IDARUBICIN, LESTAURTINIB. Patient was hospitalized. Patient recovered.
Cytarabine Side Effects Report #5706771-6
Cytarabine side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 15, 2008. Female patient, weighting 168.9 lb, was treated with Cytarabine. After drug was administered, patient experienced the following side effects: blood culture positive, escherichia infection, haemoglobin decreased, platelet count decreased, pyrexia, white blood cell count decreased. Cytarabine dosage: 14400 MG. During the same period patient was treated with IDARUBICIN, LESTAURTINIB. Patient was hospitalized. Patient recovered.
Cytarabine Side Effects Report #5714028-2
Cytarabine side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 22, 2008. Male patient, weighting 163.4 lb, was treated with Cytarabine. After drug was administered, patient experienced the following side effects: febrile neutropenia, white blood cell count decreased. Cytarabine dosage: unknown. During the same period patient was treated with ETOPOSIDE, RITUXIMAB. Patient was hospitalized. Patient recovered.
Cytarabine Side Effects Report #5962901-2
Cytarabine side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 19, 2008. Male patient, weighting 63.93 lb, was treated with Cytarabine. After drug was administered, patient experienced the following side effects: neutrophil count decreased, platelet count decreased, rash pruritic, white blood cell count decreased. Cytarabine dosage: 8240 MG. During the same period patient was treated with IDARUBICIN, LESTAURTINIB. Patient was hospitalized. Patient recovered.
Cytarabine Side Effects Report #5989117-8
Cytarabine side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 09, 2008. Female patient, weighting 165.3 lb, was treated with Cytarabine. After drug was administered, patient experienced the following side effects: platelet count decreased, syncope, vaginal haemorrhage, white blood cell count decreased. Cytarabine dosage: unknown. During the same period patient was treated with SYNTHROID. Patient was hospitalized. Patient recovered.
Cytarabine Side Effects Report #6000315-X
Cytarabine side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 11, 2008. Female patient, weighting 165.3 lb, was treated with Cytarabine. After drug was administered, patient experienced the following side effects: platelet count decreased, syncope, vaginal haemorrhage, white blood cell count decreased. Cytarabine dosage: unknown. During the same period patient was treated with DAUNORUBICIN, SYNTHROID. Patient was hospitalized. Patient recovered.
Cytarabine Side Effects Report #6003138-0
Cytarabine side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 12, 2008. Female patient, weighting 165.3 lb, was treated with Cytarabine. After drug was administered, patient experienced the following side effects: platelet count decreased, syncope, vaginal haemorrhage, white blood cell count decreased. Cytarabine dosage: unknown. During the same period patient was treated with DAUNORUBICIN, SYNTHROID. Patient was hospitalized. Patient recovered.
Cytarabine Side Effects Report #6013557-4
Cytarabine side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 18, 2008. Female patient, weighting 165.3 lb, was treated with Cytarabine. After drug was administered, patient experienced the following side effects: platelet count decreased, pyrexia, syncope, vaginal haemorrhage, white blood cell count decreased. Cytarabine dosage: unknown. During the same period patient was treated with DAUNORUBICIN, LEUKINE, SYNTHROID. Patient was hospitalized. Patient recovered.
Cytarabine Side Effects Report #6020706-0
Cytarabine side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 23, 2008. Male patient, weighting 171.3 lb, was treated with Cytarabine. After drug was administered, patient experienced the following side effects: catheter site infection, febrile neutropenia, neutrophil count decreased, staphylococcal infection
, white blood cell count decreased. Cytarabine dosage: 30400 MG. During the same period patient was treated with ETOPOSIDE, RITUXIMAB. Patient was hospitalized. Patient recovered.Cytarabine Side Effects Report #4895099-2
Cytarabine side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 26, 2006. Female patient was treated with Cytarabine. After drug was administered, patient experienced the following side effects: body temperature increased, convulsion, hypotension, hypoventilation, injury, intubation complication, pupil fixed, white blood cell count decreased. Cytarabine dosage: unknown. During the same period patient was treated with DAUNORUBICIN, DEXAMETHASONE, METHOTREXATE, PEG L, VINCRISTINE SULPHATE. Patient was hospitalized. Patient recovered.